ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses
- PMID: 12594219
- DOI: 10.1074/jbc.M209628200
ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses
Abstract
Interferons (IFNs) encode a family of secreted proteins that provide the front-line defense against viral infections. Their diverse biological actions are thought to be mediated by the products of specific but usually overlapping sets of cellular genes induced in the target cells. We have recently isolated a new human IFN-induced gene that we have termed ISG20, which codes for a 3' to 5' exonuclease with specificity for single-stranded RNA and, to a lesser extent, for DNA. In this report, we demonstrate that ISG20 is involved in the antiviral functions of IFN. In the absence of IFN treatment, ISG20-overexpressing HeLa cells showed resistance to infections by vesicular stomatitis virus (VSV), influenza virus, and encephalomyocarditis virus (three RNA genomic viruses) but not to the DNA genomic adenovirus. ISG20 specifically interfered with VSV mRNA synthesis and protein production while leaving the expression of cellular control genes unaffected. No antiviral effect was observed in cells overexpressing a mutated ISG20 protein defective in exonuclease activity, demonstrating that the antiviral effects were due to the exonuclease activity of ISG20. In addition, the inactive mutant ISG20 protein, which is able to inhibit ISG20 exonuclease activity in vitro, significantly reduced the ability of IFN to block VSV development. Taken together, these data suggested that the antiviral activity of IFN against VSV is partly mediated by ISG20. We thus show that, besides RNase L, ISG20 has an antiviral activity, supporting the idea that it might represent a novel antiviral pathway in the mechanism of IFN action.
Similar articles
-
The Interferon-Induced Exonuclease ISG20 Exerts Antiviral Activity through Upregulation of Type I Interferon Response Proteins.mSphere. 2018 Sep 19;3(5):e00209-18. doi: 10.1128/mSphere.00209-18. mSphere. 2018. PMID: 30232164 Free PMC article.
-
Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1.J Gen Virol. 2005 Aug;86(Pt 8):2221-2229. doi: 10.1099/vir.0.81074-0. J Gen Virol. 2005. PMID: 16033969
-
Antiviral activities of ISG20 in positive-strand RNA virus infections.Virology. 2011 Jan 20;409(2):175-88. doi: 10.1016/j.virol.2010.10.008. Epub 2010 Oct 30. Virology. 2011. PMID: 21036379 Free PMC article.
-
ISG20: an enigmatic antiviral RNase targeting multiple viruses.FEBS Open Bio. 2022 Jun;12(6):1096-1111. doi: 10.1002/2211-5463.13382. Epub 2022 Feb 27. FEBS Open Bio. 2022. PMID: 35174977 Free PMC article. Review.
-
Interferon-stimulated gene 20-kDa protein (ISG20) in infection and disease: Review and outlook.Intractable Rare Dis Res. 2017 Feb;6(1):35-40. doi: 10.5582/irdr.2017.01004. Intractable Rare Dis Res. 2017. PMID: 28357179 Free PMC article. Review.
Cited by
-
Synthetic Cell Lines for Inducible Packaging of Influenza A Virus.ACS Synth Biol. 2024 Feb 16;13(2):546-557. doi: 10.1021/acssynbio.3c00526. Epub 2024 Jan 23. ACS Synth Biol. 2024. PMID: 38259154 Free PMC article.
-
Interferon-stimulated genes and their antiviral effector functions.Curr Opin Virol. 2011 Dec;1(6):519-25. doi: 10.1016/j.coviro.2011.10.008. Curr Opin Virol. 2011. PMID: 22328912 Free PMC article. Review.
-
Influenza A virus inhibits TET2 expression by endoribonuclease PA-X to attenuate type I interferon signaling and promote viral replication.PLoS Pathog. 2023 Jul 27;19(7):e1011550. doi: 10.1371/journal.ppat.1011550. eCollection 2023 Jul. PLoS Pathog. 2023. PMID: 37498975 Free PMC article.
-
Lnc-ISG20 Inhibits Influenza A Virus Replication by Enhancing ISG20 Expression.J Virol. 2018 Jul 31;92(16):e00539-18. doi: 10.1128/JVI.00539-18. Print 2018 Aug 15. J Virol. 2018. PMID: 29899085 Free PMC article.
-
Disease severity is associated with differential gene expression at the early and late phases of infection in nonhuman primates infected with different H5N1 highly pathogenic avian influenza viruses.J Virol. 2014 Aug;88(16):8981-97. doi: 10.1128/JVI.00907-14. Epub 2014 Jun 4. J Virol. 2014. PMID: 24899188 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases